Caribou hires chief people officer shortly after AbbVie drops CAR-T deal
Following AbbVie’s decision to end its CAR-T therapy partnership with Caribou, the pharma announced it had brought on Reigin Zawadzki as chief people officer.
Stay updated with breaking news from Steve Davidsen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Following AbbVie’s decision to end its CAR-T therapy partnership with Caribou, the pharma announced it had brought on Reigin Zawadzki as chief people officer.
Pfizer discusses license for generic Paxlovid treatment with China; AbbVie spends $30 million upfront for Immunome partnership to bolster antibody research.
/PRNewswire/ -- AbbVie (NYSE: ABBV) and Immunome, Inc. (Nasdaq: IMNM), a clinical-stage biopharmaceutical company that utilizes its human memory B cell...
AbbVie announced a collaboration with clinical-stage biopharma company Immunome to discover as many as 10 novel oncology antibody-target pairs.
11/02/22 Life Science Leader Newsletter